je.st
news
Tag: devices
Analog Devices Fiscal Q4 Beats, Q1 Guidance Tepid
2014-11-26 21:42:29| Semiconductors - Topix.net
Analog Devices late Tuesday reported fiscal Q4 earnings that topped analysts' expectations, but its sales guidance for the current quarter missed. The Norwood, Mass.-based analog chipmaker forecast fiscal Q1 earnings per share excluding items of 58 to 64 cents, up 18% to 31% from the year-earlier quarter.
Tags: devices
fiscal
guidance
analog
Devices Leverage Smartphones And Text Messaging to Create New Tools With Potential for Construction
2014-11-25 20:46:51| ENR.com: Headline News
ENR digs through this falls new gadget lineup looking for items that might serve the needs of the industry.
Enabling The Next Generation Of Terahertz Devices
2014-11-25 17:18:56| rfglobalnet Home Page
A newly developed, single-component terahertz source was recently developed by researchers at Northwestern University. The device covers the full spectrum of terahertz radiation, comes in a small package, and is capable of functioning at room temperature. The device may enable new medical diagnostics and improve security measures at airports.
Tags: generation
devices
enabling
terahertz
Anton Paar Releases New Alcohol Measurement Devices for Microdistilleries
2014-11-24 17:59:00| Food Processing Technology
Anton Paar has released a new series of attractively priced digital alcohol meters, which will pay for themselves in a very short time, even at the smallest distillery.
Tags: releases
devices
alcohol
measurement
Merck Submits New Drug Application to the Japanese Pharmaceuticals and Medical Devices Agency for Omarigliptin, an Investigational Once-Weekly DPP-4 Inhibitor for Type 2 Diabetes
2014-11-24 14:00:00| Merck.com - Product News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the company has submitted a new drug application for omarigliptin, its investigational once-weekly DPP-4 inhibitor for the treatment of type 2 diabetes, to the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). Language: English Contact: MerckMedia:Pam Eisele267-305-3558orKim Hamilton908-740-1863 / 908-391-0131orInvestors:Justin Holko908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: for
type
application
medical
Sites : [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] next »